Ayurveda tech startup NirogStreet snaps up $12M in Sequence B funding
NirogStreet, an Ayurveda know-how platform in India, has scored $12 million in a Sequence B funding spherical led by Jungle Ventures.
It supplies a neighborhood for Ayurveda docs and an e-commerce platform that streamlines the provision chain of Ayurvedic companies and drugs. NirogStreet has onboarded round 50,000 medical practitioners and about 50 Ayurveda manufacturers.
The startup will use the proceeds from its newest investing spherical to bolster its provide chain, know-how, and companies.
Males’s well being startup Bonatra obtains pre-seed funding
Bonatra, a males’s health-focused startup from India, has raised INR 55 million ($670,000) in a pre-seed funding spherical led by ITI Development Alternatives Fund with the participation of marquee angel buyers, Jitendra Jagadev, founding father of Nestaway, and Blackbuck founder Rajesh Yabaji.
The corporate runs a know-how platform that gives personalised well being programmes concentrating on persistent circumstances of males.
In a press release, Bonatra stated that its recent funds can be used to increase its choices, construct its crew, and develop its shopper base.
Edenlux introduces AI report back to its cell eye well being app
South Korean medical machine maker Edenlux is now offering AI-generated eye well being administration experiences by means of its flagship cell app Otus Plus.
The app permits customers to check their eye well being with a paired goggle machine, do gamified eye workout routines, and obtain a watch well being report.
Its eye well being experiences now include AI-generated eye well being scores, evaluation of eye focus response pace, and outcomes of eye train video games based mostly on customers’ knowledge.
Sooner or later, Edenlux plans so as to add an enchancment indicator to its experiences, in addition to supply a service that enables customers to decide on their very own customised lenses for eye workout routines and use accrued knowledge to supply a watch well being rating report.
Cha Vaccine ties up with MOGAM for AI drug discovery
The MOGAM Institute for Biomedical Analysis has signed a memorandum of understanding with the Cha Vaccine Institute for AI drug discovery.
They’ll cooperate to develop new medication and enhance drug substances utilizing MOGAM’s AI algorithms, which can be examined utilizing medical knowledge from Cha Vaccine. Later, they’ll conduct joint research and apply for co-patents.